Celgene

This Phase 3 study tested an investigational drug called CC-93538 for adults and adolescents in Japan with eosinophilic gastroenteritis, a rare inflammatory gut disease. The trial aimed to see if the drug could reduce gut inflammation and improve symptoms like stomach pain, heavi…

This early-stage study tested a new drug called CC-94676 in men with advanced prostate cancer that had spread and was no longer responding to standard hormone therapies. The main goal was to find a safe dose and understand how the drug behaves in the body. Researchers also looked…

This study tested the long-term safety and effectiveness of an oral medication called RPC1063 for people with moderate to severe ulcerative colitis. It involved 877 participants who had already been in previous RPC1063 trials, allowing them to continue treatment for several more …

This study tested whether a daily oral medication called ozanimod could help control symptoms and induce remission in Japanese adults with moderate to severe ulcerative colitis. About 198 participants were randomly assigned to receive either the drug or a placebo pill for an init…

This study tested an experimental cell therapy called bb2121 in adults with multiple myeloma, a cancer of plasma cells. It focused on people whose cancer had come back after several treatments or who were at high risk of early relapse. The therapy involves collecting and genetica…

This early-stage study tested how a new drug called golcadomide behaves in people with moderate to severe liver problems compared to healthy volunteers. Researchers gave a single dose to 29 participants to measure drug levels in the blood and check for safety issues. The goal was…